AKC Canine Health Foundation funds clinical trial to study cannabidiol in treating drug-resistant epilepsy in dogsSeptember 14, 2017By Veterinary Practice News Editors The AKC Canine Health Foundation (CHF), which has funded more than $2 million for canine epilepsy research, launched an initiative in 2017 to further understand the most common neurological disorder that affects pure- and mixed-breed dogs. Improved treatments are urgently needed, especially for dogs with drug-resistant epilepsy or where side effects of currently available drugs are not tolerated, according to the organization. To that, the CHF has announced the beginning a major clinical trial to study the use of cannabidiol to treat drug resistant epilepsy in dogs. Stephanie McGrath, MS, DVM, DACVIM (Neurology), at Colorado State University's College of Veterinary Medicine and Biomedical Sciences, will lead "Efficacy of Cannabidiol (CBD) for the Treatment of Canine Epilepsy." According to Dr. McGrath, up to 30 percent of dogs receiving standard anti-epileptic therapy remain uncontrolled for their seizures, and the side effects of the antiepileptic drugs are often unacceptable. CBD, a nonpsychotropic component of the Cannabis sativa plant, has been shown to have anticonvulsant properties; this randomized, double-blinded, placebo-controlled, crossover clinical trial study will be utilized to prove its effectiveness, she stated. "The timeliness and importance of research into the role of cannabis in …
SPONSORED CONTENTYour Parasite Protection Recommendation, SimplifiedManaging parasite prevention doesn’t have to be complicated. Discover a single solution that protects against multiple threats. + Learn More
AHS urges best practices to prevent, minimize heartworm transmission in dogsSeptember 14, 2017By Veterinary Practice News Editors The American Heartworm Society (AHS) has announced a new set of veterinary best practices for minimizing heartworm transmission in dogs relocated due to recent natural disasters, a cross-country family move, or other circumstances. The guidelines include recommendations for heartworm testing, treatment, and prevention, and were developed in collaboration with the Association of Shelter Veterinarians (ASV). "Preventing transmission of D. immitis has always been a focus of the AHS Heartworm Guidelines," sais Chris Rehm, DVM, AHS president. "However, we believe we need to do more, given the potential for heartworm-positive dogs to serve as reservoirs for infection. For example, if a microfilaria-positive dog is rescued in one state and subsequently moved to a new home in another state where nearby pets are unprotected, mosquitoes feeding on the new dog can quickly become heartworm vectors. The results can be disastrous for unprotected pets in the vicinity." Measures can be taken to protect the health of both infected animals and their new neighbors, according to Dr. Rehm. While the ideal scenario is to treat infected dogs before transporting or traveling with them, situations often dictate that infected animals cannot undergo …
UA researchers get $4.8 million to develop valley fever vaccineSeptember 6, 2017The University of Arizona's (UA) efforts to prevent valley fever in dogs received a boost in the way of a $4.8 million, four-year grant from the National Institutes of Health, providing the funding necessary to get the disease's delta-CPS1 vaccine to market, according to John Galgiani, MD, director of the UA Valley Fever Center for Excellence and principal investigator of the NIH grant. The vaccine, which could hit the market as soon as five years from now, will be developed for dogs first, but the end goal is to use it in humans, as well, according to Dr. Galgiani. There is currently no prevention or cure for valley fever, which is potentially deadly in both humans and dogs. Every year, an estimated 30,000 people and 60,000 dogs in Arizona get sick from valley fever, also known as coccidioidomycosis, according to UA. The cocci fungus that causes the disease is found mainly in dusty areas of Arizona and California, and it contributed to the deaths of 54 people in Arizona last year, state officials said. Treatment for valley fever is expensive: $4 to $6 per-day meds, blood tests, and additional …
